Could a vaccine fight Alzheimer's? new trial begins

NCT ID NCT05642429

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a vaccine called AV-1959D in 48 people with early Alzheimer's disease. The vaccine aims to train the immune system to target harmful amyloid plaques in the brain. The main goal is to check if the vaccine is safe and tolerable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Accel Research

    Decatur, Georgia, 30033, United States

  • Alzheimer's Research and Treatment Center

    Wellington, Florida, 33414, United States

  • Banner Alzheimer's Institute

    Phoenix, Arizona, 85006, United States

  • Global Medical Institutes Princeton Medical Institute

    Princeton, New Jersey, 08540, United States

  • Hoag Memorial Hospital

    Newport Beach, California, 92663, United States

  • University of South Florida

    Tampa, Florida, 33613, United States